Skip to content

Operating Income at other companies

Baxter International logo
Baxter InternationalBAX
$66M+13.8%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$1.86B+8.6%
ADMA Biologics logo
ADMA BiologicsADMA
$58.27M+67.1%
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
$141.5M+24.6%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
-$6.2M+32.1%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
-$8.48M-37.6%

Other financials

Income statement

See full
Revenue$23.2M-36.4%
Gross profit$4.5M-68.1%
Net income-$15.0M-1,206%
EPS (diluted)-$0.43-1,333%

Balance sheet

See full
Cash & equivalents$20.8M+152%
Total debt$156.9M+1,310%
Total equity-$28.4M-2,229%
Total assets$225.5M-5.8%

Cash flow

See full
Operating cash flow$4.7M
CapEx$1.1M-46.7%
Free cash flow$3.6M

Valuation

See full
Market cap$196.92M-35.4%
Enterprise value$333.06M+8.3%
P/S1.6×+0.5×

Profitability

See full
Gross margin31.3%-1.4pp
Operating margin-14.5%-2.2pp
Net margin-30%
FCF margin-36.4%

Returns & leverage

See full
Return on equity-612.1%
Debt / equity8.3×-1.5×
Current ratio3.8×+0.9×

Where this comes from

Reported directly by Lifecore Biomedical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lifecore Biomedical, Inc.'s operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lifecore Biomedical, Inc.'s operating income?
Lifecore Biomedical, Inc. (LFCR) reported operating income of -$4.67M in Q1 2026.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.